WNC · Wabash National Corp.

Current Thesis

Wabash National Corporation’s tariff-supported recovery depends on an affirmative final China injury decision and backlog converting into narrower losses before the market breaches the published $11.50 weekly-close threshold. Commerce’s affirmative antidumping and countervailing-duty determinations were published on 2026-08-31; publication settles the timing uncertainty in the August coverage, but does not settle the remaining injury decision. Commerce antidumping determination, Commerce countervailing-duty determination.

The narrative is maturing — an inference supported by the completed 2026-08-31 Commerce publication and the 2026-09-11 adjusted close of $12.55, still up 30.0% over three months but 12.3% below the supplied 52-week high. The remaining economic test is concrete: Wabash’s 2026-07-29 release reported $956 million of June-end backlog and guided Q3 revenue to $440–460 million with a loss of $0.45 per share. Those figures describe a recovery case whose profitability remains unproven. Wabash Q2 results.

Bullish and bearish views on Wabash National Corp.

The model's bull view on Wabash National Corp. (WNC), in brief: Commerce findings remain affirmative. The 2026-08-31 notices confirm affirmative China determinations on both duty tracks. The inference is that import protection can support domestic manufacturers; a negative final injury determination would defeat that policy leg. Commerce… The bear view: Final injury remains unresolved. The US International Trade Commission (ITC) calendar lists a 2026-09-25 vote and 2026-10-08 determination issuance. A negative China injury decision would prevent the affirmative Commerce findings from producing the final orders assumed by the… Both cases follow in full.

Bull Case

• Commerce findings remain affirmative. The 2026-08-31 notices confirm affirmative China determinations on both duty tracks. The inference is that import protection can support domestic manufacturers; a negative final injury determination would defeat that policy leg. Commerce final determination.
• Backlog supports the recovery hypothesis. Wabash reported $956 million of backlog at 2026-06-30, up 14% from the preceding quarter, in its 2026-07-29 release. A Q3 backlog below that amount would contradict the proposed sustained rebuild. Wabash Q2 results.
• Guidance provides a measurable test. The 2026-07-29 Q3 outlook called for $440–460 million of revenue and a loss of $0.45 per share. Delivery below the revenue range or a larger per-share loss would contradict the expected sequential improvement. Wabash Q2 results.

Bear Case

• Final injury remains unresolved. The US International Trade Commission (ITC) calendar lists a 2026-09-25 vote and 2026-10-08 determination issuance. A negative China injury decision would prevent the affirmative Commerce findings from producing the final orders assumed by the thesis. ITC investigation calendar, Commerce final determination.
• Revenue has not restored profitability. Q2 revenue of $417.2 million accompanied a $25 million operating loss under generally accepted accounting principles and a $24 million adjusted operating loss, according to the 2026-07-29 release. The backlog increase alone therefore does not establish profitable demand. Wabash Q2 results.
• Financing accompanies the recovery period. Wabash’s 2026-07-16 offering announcement priced $130 million of convertible senior unsecured notes carrying a 4.00% coupon and maturing in 2032. This is observable issuance during the recovery period; it does not establish insider selling or retail crowding.

Setup & Price Structure

The supplied adjusted market series records a 2026-09-11 close of $12.55, a 52-week high of $14.31 and a three-month gain of 30.0%. Its 14-day relative strength index was 54.8. These observations show that substantial medium-term appreciation coexists with a retreat from the high; they do not identify who supplied the demand.

The $11.50 level remains the analytical invalidation threshold published on 2026-08-30. A weekly close below $11.50 would break the recovery structure used in this coverage. Moving-average values and verified retail-flow measurements are missing, so neither extension above a rising average nor a crowded retail trade is established.

Catalyst Calendar (next 30 days)

• 2026-09-22 — Final party comments. The ITC calendar lists this comment deadline before the scheduled vote. ITC investigation calendar.
• 2026-09-25 — Scheduled ITC vote. The calendar supplies a specific date in place of the previously unconfirmed October estimate; it remains subject to schedule changes. ITC investigation calendar.
• 2026-10-08 — Scheduled determination and views. The ITC calendar lists issuance on this date, providing the written outcome behind the vote. ITC investigation calendar.
• ~2026-10-28, estimated — Q3 results. This later event is the economic test of the 2026-07-29 guidance and June-end backlog. The company-confirmed reporting date is not established; the estimate remains provisional.

Elapsed catalysts

• 2026-09-18 — ITC information release. The final-phase notice schedules release to parties of information not previously available for comment; this is a procedural step, not the injury decision. ITC scheduling notice, published 2026-06-17. (passed 2d ago)

What Would Change Our Mind

Loss of the published recovery threshold would end the price thesis: a weekly close below $11.50 breaches the level specified in the 2026-08-30 coverage. An adverse final China injury determination would separately remove the policy support assumed after Commerce’s 2026-08-31 publication. Commerce final determination.

The positive outcome requires an affirmative final China injury decision followed by Q3 revenue meeting at least the $440 million lower end of July guidance, a per-share loss no worse than $0.45 and backlog holding at least the $956 million reported at 2026-06-30, before the weekly threshold is breached. Those are explicit thesis conditions, not additional company forecasts.

Correlation Notes

This remains a single-name setup: the 2026-09-11 market observations supplied for Wabash contain no peer-return series capable of establishing a freight-sector correlation. The company’s 2026-07-29 backlog increase is direct evidence about Wabash; it cannot establish a broad trailer replacement cycle. A group-led explanation remains an inference requiring corroborating carrier demand and peer-order evidence, and would be contradicted by Wabash’s Q3 backlog falling below its June-end level.